🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
QUESTIONS AND OBJECTIVES OF ALL-MB-2008 STUDY 1. Whether the early PEG-asp...
Status
Unknown
Location
Republican Research and Practical Center of Radiation Medicine
Start Date
2008-02
Trial ID
NCT01953770
This phase III trial studies whether inotuzumab ozogamicin added to post-in...
Status
Recruiting
Location
Children's Hospital of Alabama
Start Date
2019-10-31
Trial ID
NCT03959085
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
MBCCOP - University of South Alabama
Start Date
1995-07
Trial ID
NCT00002665
This clinical trial is studying the side effects of Erwinia asparaginase an...
Status
Completed
Location
University of Alabama at Birmingham Cancer Center
Start Date
2008-02-11
Trial ID
NCT00537030
Treatments Being Tested
This Phase II trial is studying how well giving epratuzumab together with a...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2005-02
Trial ID
NCT00098839
Drugs used in chemotherapy use different ways to stop cancer cells from div...
Status
Completed
Location
Children's Oncology Group
Start Date
2001-04
Trial ID
NCT00016302
Treatments Being Tested
This is a phase 1/2 study of a drug called Ixazomib in combination with cyt...
Status
Active Not Recruiting
Location
Children's Hospital Los Angeles
Start Date
2019-02-12
Trial ID
NCT03817320
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
Comprehensive Cancer Center at University of Alabama at Birmingham
Start Date
2000-04
Trial ID
NCT00005585
This pilot phase II trial studies the side effects of azacitidine and combi...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2017-04-01
Trial ID
NCT02828358
Treatments Being Tested
AINV18P1 is a Phase 1 study where palbociclib will be administrated in comb...
Status
Completed
Location
Children's Hospital of Alabama
Start Date
2019-04-11
Trial ID
NCT03792256